NPI registry status
Active
2026 NPPES data Pediatric Endocrinology Physician NPI 1336567312 M.D.
Verify on CMS → Daniel Tilden, M.D.
Pediatric Endocrinology Physician in Kansas City, Kansas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,459 in Pediatric Endocrinology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
424
Medicare Part D claims · 90 beneficiaries · Pediatric Endocrinology Physician avg: 151
Generic prescribing
41%
generic claims · 55% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.9/100
▲ 9 pts above national avg 83.1 · Exceptional
Industry payments
$67.41
4 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Daniel Tilden, M.D. reported a CMS MIPS final score of 91.9/100 - above the 83.1 national average - and filed 424 Medicare Part D claims in 2023.
- 91.9/100
- MIPS score · +9 vs avg
- 424
- Part D claims, 2023
- 41%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Daniel Tilden, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
92 Top 37% higher than 63% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Daniel Tilden, M.D. sits
This provider among pediatric endocrinology physician peers
Across the 61 pediatric endocrinology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Daniel Tilden, M.D. writes more Part D claims than 89% of them and scores higher on MIPS quality than 74% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pediatric endocrinology physician peer from a representative sample of 60; the gold marker is Daniel Tilden, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Daniel Tilden, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Daniel Tilden, M.D.?
High performer (top quartile)Primary specialty
Pediatric Endocrinology Physician
Medicare Part D claims
424 181% vs specialty avg
MIPS final score
91.9/100 8.8 pts vs avg
Specialty distribution in Kansas
How Pediatric Endocrinology Physician compares to other specialties among Kansas providers
Medicare quality performance, MIPS
Daniel Tilden, M.D.'s 2023 MIPS final score plotted against the Pediatric Endocrinology Physician national average
- MIPS Final Score
- 91.9/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pediatric Endocrinology Physician) - 91.9/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Daniel Tilden, M.D. appears in the CMS NPPES registry as a Pediatric Endocrinology Physician provider holding M.D. credentials at 4000 CAMBRIDGE ST # MS 2024, Kansas City, KS, 66160, with a listed phone of (913) 558-6022. NPI 1336567312 was issued on 04/07/2014.
Medicare Part D records for calendar year 2023 show 424 prescription claims written by this provider, covering 90 Medicare beneficiaries and totaling roughly $250K in drug spend, split 55% brand-name and 41% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.9/100 for the 2023 performance year (Quality 75.2), compared with the national average of 83.1.
Pediatric Endocrinology Physician is a narrow specialty nationwide, with 1,459 enrolled providers across 51 states and an average of 151 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1336567312 |
|---|---|
| Specialty | Pediatric Endocrinology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/07/2014 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
91.8902
Final Score
Avg: 83.1
75.1734
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Daniel Tilden, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Kansas University Physicians Inc
Gladstone, MO
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Tilden, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$67
Largest payer
SANOFI-AVENTIS U.S. LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Daniel Tilden, M.D. - brand share 55.0%
Pediatric Endocrinology Physician average
55% brand-name claims vs 41% generic, on 424 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
424
Total Claims
$250K
Total Drug Cost
90
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 864
- Total Day Supply
- 25,497
- Brand vs Generic
- 55% brand / 41% generic
- Brand Drug Cost
- $239K
- Generic Drug Cost
- $9K
Patient Demographics
- Average Patient Age
- 65.9 years
- Avg HCC Risk Score
- 2.36
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 26, 65-74: 51, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Daniel Tilden, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
45 claims
- Ozempic
Ozempic
45 claims
- Jardiance
Jardiance
29 claims
- Synthroid
Synthroid
24 claims
- Metformin Hcl Er
Metformin Hcl Er
18 claims
- Trulicity
Trulicity
18 claims
- Hydrocortisone 15
Hydrocortisone
15 claims
- Metformin Hcl 15
Metformin Hcl
15 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 45 |
| Ozempic Semaglutide | 45 |
| Jardiance Empagliflozin | 29 |
| Synthroid Levothyroxine Sodium | 24 |
| Metformin Hcl Er Metformin Hcl | 18 |
| Trulicity Dulaglutide | 18 |
| Hydrocortisone | 15 |
| Metformin Hcl | 15 |
| Lisinopril | 14 |
| Rosuvastatin Calcium | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pediatric Endocrinology Physician Overview
How Daniel Tilden, M.D. fits within the Pediatric Endocrinology Physician landscape nationally.
1,459
Pediatric Endocrinology Physician Providers in US
51
States with Pediatric Endocrinology Physician
151
Avg Claims per Provider
Daniel Tilden, M.D.'s 424 claims are above the specialty average of 151.
Nearby Pediatric Endocrinology Physician Providers in Kansas
Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as Tilden.
Fadi Al Muhaisen
Wichita, KS
Dr. Patria Alba Aponte
MD
Topeka, KS
Dr. Christopher Blue
MD
Wichita, KS
Dr. Kenneth Dykstra
MD
Wichita, KS
Dr. Katarina Gambosova
M.D.
Lawrence, KS
Compare Pediatric Endocrinology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Kansas medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pediatric Endocrinology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Kansas
Frequently Asked Questions
What is Daniel Tilden, M.D.'s specialty? ▼
Daniel Tilden, M.D. specializes in Pediatric Endocrinology Physician and practices in Kansas City, Kansas. Credentials: M.D..
How much does Daniel Tilden, M.D. prescribe under Medicare Part D? ▼
In 2023, Daniel Tilden, M.D. wrote 424 Medicare Part D claims totaling $250K in drug costs for 90 beneficiaries.
What is Daniel Tilden, M.D.'s Medicare quality score? ▼
Daniel Tilden, M.D. has a CMS MIPS Final Score of 91.9/100 (Quality: 75.2). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Daniel Tilden, M.D. located? ▼
Daniel Tilden, M.D. is located at 4000 CAMBRIDGE ST # MS 2024, Kansas City, KS, 66160. Phone: (913) 558-6022.
What is Daniel Tilden, M.D.'s NPI number? ▼
Daniel Tilden, M.D.'s National Provider Identifier (NPI) is 1336567312, issued on 04/07/2014.
Does Daniel Tilden, M.D. prescribe more brand-name or generic drugs? ▼
Daniel Tilden, M.D.'s prescribing is 55% brand-name and 41% generic drugs by claim count, with $239K in brand drug costs.
How many Pediatric Endocrinology Physician providers are there in the US? ▼
There are 1,459 Pediatric Endocrinology Physician providers across 51 states in the US. The average Pediatric Endocrinology Physician provider writes 151 Medicare Part D claims per year.
What drugs does Daniel Tilden, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Daniel Tilden, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Ozempic, Jardiance. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daniel Tilden, M.D. accept Medicare? ▼
Daniel Tilden, M.D. appears in CMS Medicare data with 424 Part D claims and 90 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daniel Tilden, M.D.'s credentials? ▼
Daniel Tilden, M.D.'s NPI is 1336567312 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.